BEGIN:VCALENDAR
PRODID:-//Pixl8//Eventfolio//EN
VERSION:2.0
X-WR-TIMEZONE:Europe/Brussels
CALSCALE:GREGORIAN
METHOD:PUBLISH
CLASS:PUBLIC
BEGIN:VTIMEZONE
TZID:Europe/Brussels
LAST-MODIFIED:20260306T231828Z
TZURL:https://www.tzurl.org/zoneinfo-outlook/Europe/Brussels
X-LIC-LOCATION:Europe/Brussels
BEGIN:DAYLIGHT
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
DTSTART:19700329T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
DTSTART:19701025T030000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels;VALUE=DATE:20250403
DTEND;TZID=Europe/Brussels;VALUE=DATE:20250404
DTSTAMP:20260411T052719Z
UID:{B10C87A0-DE72-40FB-9C1D154A24565AD3}
LOCATION:Online
SUMMARY:Pharma-biotech product & company valuation
DESCRIPTION:In the high-stakes world of biotechnology and pharmaceuticals, traditional valuation methods fall short. The industry presents unique challenges that require specialised expertise: High R&D Attrition Rates, Extended Investment Cycles and Complex IP Landscapes. This hands-on introductory course equips you with practical valuation tools essential for Financing rounds and investment decisions, Mergers & Acquisitions (M&A), Licensing deals and partnerships, Strategic development planning, Portfolio optimisation.\n
 \n
 Event details: https://www.lisah.org/events/pharma-biotech-product-company-valuation-april-2025.html
PRIORITY:1
END:VEVENT
END:VCALENDAR